Hepatitis B after transplantation: competition between the recipient virus and the donor virus.
Mutimer
David
D
D004279:DNA, Viral / Q000032:analysis; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006509:Hepatitis B / Q000188:drug therapy / Q000276:immunology / Q000821:virology*; D006510:Hepatitis B Antibodies / Q000032:analysis* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis* / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D016031:Liver Transplantation; D009711:Nucleotides / Q000627:therapeutic use; D016133:Polymerase Chain Reaction; D013048:Specimen Handling; D014019:Tissue Donors; D019737:Transplants / Q000821:virology
D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins; D009711:Nucleotides; D019259:Lamivudine